MedCap Management

Management criteria checks 3/4

MedCap's CEO is Anders Dahlberg, appointed in Nov 2020, has a tenure of 3.42 years. total yearly compensation is SEK6.69M, comprised of 44.3% salary and 55.7% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth SEK8.20M. The average tenure of the management team and the board of directors is 3.4 years and 1.9 years respectively.

Key information

Anders Dahlberg

Chief executive officer

kr6.7m

Total compensation

CEO salary percentage	44.3%
CEO tenure	3.4yrs
CEO ownership	0.1%
Management average tenure	3.4yrs
Board average tenure	1.9yrs

Recent management updates

Recent updates

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

CEO Compensation Analysis

How has Anders Dahlberg's remuneration changed compared to MedCap's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	kr172m
Sep 30 2023	n/a	n/a	kr150m
Jun 30 2023	n/a	n/a	kr149m
Mar 31 2023	n/a	n/a	kr123m
Dec 31 2022	kr7m	kr3m	kr118m
Sep 30 2022	n/a	n/a	kr118m
Jun 30 2022	n/a	n/a	kr107m
Mar 31 2022	n/a	n/a	kr102m
Dec 31 2021	kr6m	kr3m	kr97m

Compensation vs Market: Anders's total compensation ($USD611.88K) is about average for companies of similar size in the Swedish market ($USD584.08K).

Compensation vs Earnings: Anders's compensation has been consistent with company performance over the past year.

CEO

Anders Dahlberg (47 yo)

3.4yrs

Tenure

kr6,692,000

Compensation

Mr. Anders Dahlberg serves as the Chief Executive Officer at MedCap AB, since November 1, 2020. Previously he served as Partner of Applied Value AB till August 2017, where he also had been a Chairman. Mr....

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Anders Dahlberg	Chief Executive Officer	3.4yrs	kr6.69m	0.13% SEK 8.2m
Kristina Ekblad	Chief Financial Officer	3.9yrs	no data	no data
Lars Ångman	Investment Manager	2.3yrs	no data	0.034% SEK 2.1m

3.4yrs

Average Tenure

Experienced Management: MCAP's management team is considered experienced (3.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Karl Tobieson	Chairman	2.3yrs	kr1.79m	1.23% SEK 76.6m
Torgny Svensson	Member of Scientific Advisory Board	no data	no data	no data
Lena Söderström	Independent Director	1.9yrs	kr117.00k	no data
Karl-Olov Fagerström	Member of Scientific Advisory Board	no data	no data	no data
Staffan Nilsson	Member of Scientific Advisory Board	no data	no data	no data
Gunnar Kratz	Member of Scientific Advisory Board	no data	no data	no data
Holland Cheng	Member of Scientific Advisory Board	no data	no data	no data
Otto Ankarcrona	Independent Director	1.3yrs	no data	no data
David Jern	Independent Director	2.3yrs	kr170.00k	no data
Malin Enarson	Independent Director	1.3yrs	no data	no data
Anna Torner	Independent Director	1.9yrs	kr117.00k	no data

1.9yrs

Average Tenure

52yo

Average Age

Experienced Board: MCAP's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

MedCap Management

Management criteria checks 3/4

Key information

Recent management updates

MedCap AB (publ), Annual General Meeting, May 06, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Recent updates

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207

MedCap AB (publ) to Report Q2, 2021 Results on Jul 30, 2021

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure